Using a novel method, Weizmann Institute of Science researchers map 16 types of simultaneous changes in dozens of samples; ...

All-RNA, non-viral, LNP-based PRINT™ platform is designed to develop safer, durable, one-time therapies for a broad range of unmet needsAddition ...

Ribosomes—the tiny factories that build proteins in our cells—don't all work with the same efficiency. Researchers from Japan have discovered that ...

For years, ETH researchers have been investigating a molecular complex that plays a key role in protein synthesis. They have ...

This article explores how challenges such as sequence optimization, immune activation and off-target effects are being addressed to enhance the safety, durability and efficacy of RNA therapeutics.

Mycobacterium tuberculosis, the bacterium responsible for tuberculosis, produces pairs of poison-antidote, called ...

Researchers investigate into the various lineages of Asgard archae, and determine one related to Hods as the ancestor of ...

Researchers developed and validated a non-invasive urinary microRNA aging clock using extracellular vesicle miRNAs from more ...

This sibling-controlled East Asian study found that autistic individuals, their unaffected siblings, and typically developing ...

This study reports a valuable method to predict the capacity of a candidate probiotic bacterium to metabolically outcompete a bacterial pathogen in the ecological niche of the murine respiratory tract ...